CapMan’s Q4 fee income of EUR 16.7m grew 25% y/y and was 10% ahead of our estimate of EUR 15.
Redeye comments on W5 Solutions Q4-results which were much stronger than expected, beating both our ...
Redeye comments on Carasent’s Q4 report, showing slightly lower organic ARR growth yet solid scalabi...
All lines are positive – there is nothing that we would not like.
* Overall solid report; focus turning to capital allocation * We cut '26e-'27e adj.
Taaleri's Q4 results came in clearly above our expectations, owing to good performance in all key op...
Redeye comments on Vertiseit’s Q4 report showing somewhat lower organic ARR growth and higher OPEX t...
Careium continued to grow organically in the quarter.
* Margin pressure to remain in H1'26e * We cut our '26-'27 EBIT estimates by 15% and 9% * Share is t...
Siili is shaping itself to benefit from the structural market change over time.
* Q4 boosted by Valuation France divestment * We cut 2026e-27e EBIT by 6-8% * 2025e-27e EV/EBIT of 4...
Redeye comments briefly on Insplorion’s announcement following the Board’s strategic review.
Finnair’s EUR 789.5m Q4 revenue was quite close to estimates, but the EUR 61.
SRV’s Q4 figures and 2026 outlook were in line with our expectations.
Redeye retains its positive view of CombinedX following the Q4 report.
Careium reported 1% y/y sales growth in Q4, leading to sales 1% above SEBe.
NoHo Partners reported Q4 EBIT of EUR 11.8m (-3.7% y/y), 4% above Vara Research consensus and 6% abo...
* Adj. EBITA -4% vs ABGSC and FactSet cons * Denmark remains challenging, will drive 1-2% est cuts *...
Taaleri’s Q4 2025 continuing earnings of EUR 12.2m increased by 17% y/y and came 18% above our estim...
Redeye updates on EG7 ahead of Q4-results (due 17 February) where we expect the results to remain la...
